| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), IMUX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | Neermann Joerg67 | Director | Buy | 18,000 | $1.39 | $25,020.00 | New | +41.2% | -20.6% | |
| Nov 22, 2022 | Vitt Daniel57 | President and CEO | Buy | 8,000 | $1.35 | $10,799.20 | +2.2% | +46.6% | -19.8% | |
| Nov 7, 2022 | Whaley Glenn49 | Chief Financial Officer | Buy | 5,000 | $1.50 | $7,475.00 | +32.2% | +82.5% | -19.6% | |
| Jun 3, 2022 | Vitt Daniel57 | President and CEO | Buy | 5,000 | $3.10 | $15,499.50 | +1.4% | +31.3% | -53.4% | |
| Jun 3, 2022 | Whaley Glenn49 | Chief Financial Officer | Buy | 3,500 | $3.05 | $10,657.50 | +38.6% | +31.3% | -53.4% | |
| May 12, 2022 | Muehler Andreas | Chief Medical Officer | Buy | 3,500 | $5.10 | $17,850.00 | +1.2% | -0.2% | -66.2% | |
| May 12, 2022 | Whaley Glenn49 | Chief Financial Officer | Buy | 3,000 | $5.08 | $15,240.00 | +49.4% | -0.2% | -66.2% | |
| May 12, 2022 | Nash Duane | Executive Chairman | Buy | 10,000 | $5.03 | $50,300.00 | +83.1% | -0.2% | -66.2% | |
| Aug 10, 2021 | Vitt Daniel57 | President and CEO | Buy | 1,000 | $9.60 | $9,600.00 | +0.3% | +1.3% | -47.4% | |
| Aug 10, 2021 | Nash Duane | Executive Chairman | Buy | 1,000 | $9.80 | $9,800.00 | +7.1% | +1.3% | -47.4% |